Comparative Efficacy and Safety of Fenoverine

• Status: Completed
• Trial end date: 2013-06-01

Summary

It is a randomized double-blind parallel phase IV study to compare Fenoverine and Trimebutine maleate in the efficacy and safety.

Study Hypothesis: Fenoverine is non-inferior to Trimebutine maleate in its efficacy and safety.

• Phase: Phase 4

Details

• Lead Sponsor: Bukwang Pharmaceutical
• Treatments: Fenoverine; Maleic acid; Trimebutine